Results for “”

Entry Author Date Location
Xconomy Awards On-Demand ‘Meet the Finalists’ Webcast Series Continues This Week 09/21/20 Boston
Illumina to Acquire Cancer Diagnostics Developer Grail in $8B Deal 09/21/20 San Francisco
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More 09/18/20 National
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D 09/17/20 Boston
Moderna CMO Talks COVID-19 Vaccine at the Xcelerate Keynote Series 09/16/20 Boston
Join Xconomy Next Week at the Virtual Xcelerate Keynote Series at Biotech Week Boston 09/14/20 Boston
Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More 09/11/20 National
Bio Roundup: Pharma M&A, AbbVie’s Cancer Bet, Biofourmis Bucks & More 09/04/20 National
Lumen Bioscience Lands $16M to Engineer “Edible” Antibody Drugs 09/02/20 Seattle
Early Bird Sale for Xcelerate at Biotech Week Boston Ends This Friday 08/31/20 Boston
Akcea Therapeutics Is Returning to Parent Ionis Pharma in $500M Buyout 08/31/20 Boston
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases 08/26/20 Boston
Acadia Pharma Acquires CerSci, Potential Pain Meds in $52.5M Buyout 08/26/20 San Diego
FDA Adds Plasma as 2nd COVID-19 Treatment Under Emergency Guidelines 08/24/20 National
Bio Roundup: J&J Buyout, BioMarin Rebuffed, Poseida on Hold & More 08/21/20 National
Harmony Bio and Inhibrx Raise Combined $247M in Public Market Debuts 08/20/20 National
Patient Death in Poseida Prostate Cancer Study Prompts Clinical Hold 08/18/20 San Diego
Bio Roundup: Seres Soars, MesoBlast Vote, Duchenne Decision & More 08/14/20 National
Ligand to Spend $438M to Add Protein Maker Pfenex to Technology Lineup 08/11/20 San Diego
Bayer Boosts Women’s Health Drug Pipeline, Paying $425M for KaNDy 08/11/20 Europe
Bio Roundup: A Telehealth Combo, FDA’s BCMA OK, Biogen’s Bet & More 08/07/20 National
Biogen to Pay Denali $1B to Partner on Parkinson’s Drug & Other Neuro Meds 08/06/20 San Francisco
Bio Roundup: Cerevel’s Shell, Thrive’s Rise, Drug Price Drama & More 07/31/20 National
Amid Boom Days for Biotech, Inhibrx Lines Up Another IPO Effort 07/29/20 San Diego
Thrive Adds $257M, Plans Pivotal Trial of Early Cancer Detection Test 07/29/20 National
Telehealth Firm AristaMD Adds $24M to Link Primary Docs With Specialists 07/27/20 San Diego
Bio Roundup: Jazz Drug OK’d, Gilead’s Bet, Moderna Patent Decision & More 07/24/20 National
Acadia Halts Work on Depression Drug After Late-Stage Trial Failure 07/21/20 San Diego
Exalys Launches With $15M to Treat Postoperative Delirium & More 07/17/20 San Diego
Page 1 of 189 next page »